# Cytel

applies AI to HEOR through case studies navigating regulatory and HTA guidance, alongside its established biostatistics practice, and analyzes potential impacts of US drug-pricing reform on pharma HEOR evidence generation.


Source: https://cn.bioecon.ru/companies/cytel/
Updated: 2026-08-16

- 国家: United States

## 技术

- [卫生经济学与结果研究（HEOR）服务](https://cn.bioecon.ru/technology/heor-b2b-services/)